Mackay Martin

EVP & Global Head of R&D at ALEXION PHARMACEUTICALS INC

Sold, on record
$18.4M
Dollars the filings state
Form 4 sales
13
Latest Mar 1, 2017
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale ALEXION PHARMACEUTICALS INCPlan not stated
    May 14, 2015 2015

    Sold 4,056 shares at $160.33 ($650k)

    Mackay Martin, EVP & Global Head of R&D

    Sold 11% of holdings ($5.9M position)32,893 shares left1x usual sizeFiling

  2. 2 Form 4 sale ALEXION PHARMACEUTICALS INCUnusual
    Aug 3, 2015 +81 days

    Sold 43,500 shares at $196.52 ($8.5M)

    Mackay Martin, EVP & Global Head of R&D

    Sold 56.9% of holdings ($15M position)32,893 shares left10.9x usual sizeFiling

  3. 3 Form 4 sale ALEXION PHARMACEUTICALS INCPlan not stated
    Feb 8, 2016 +189 days

    Sold 3,971 shares at $139.84 ($555k)

    Mackay Martin, EVP & Global Head of R&D

    Sold 8.9% of holdings ($6.3M position)40,785 shares left1x usual sizeFiling

  4. 4 Form 4 sale ALEXION PHARMACEUTICALS INCPlan not stated
    Feb 29, 2016 +21 days

    Sold 1,000 shares at $138.91 ($139k)

    Mackay Martin, EVP & Global Head of R&D

    Sold 2.1% of holdings ($6.6M position)46,785 shares left0.2x usual sizeFiling

  5. 5 Form 4 sale ALEXION PHARMACEUTICALS INCPlan not stated
    May 16, 2016 +77 days

    Sold 4,097 shares at $139.20 ($570k)

    Mackay Martin, EVP & Global Head of R&D

    Sold 8.8% of holdings ($6.5M position)42,688 shares left1x usual sizeFiling

  6. 6 Form 4 sale ALEXION PHARMACEUTICALS INCPlan not stated
    Feb 6, 2017 +266 days

    Sold 2,728 shares at $125.70 ($343k)

    Mackay Martin, EVP & Global Head of R&D

    Sold 6.4% of holdings ($5.4M position)39,960 shares left0.7x usual sizeFiling

  7. 7 Form 4 sale ALEXION PHARMACEUTICALS INCPlan not stated
    Feb 9, 2017 +3 days

    Sold 217 shares at $126.84 ($28k)

    Mackay Martin, EVP & Global Head of R&D

    Sold 0.5% of holdings ($5.1M position)39,743 shares left0.1x usual sizeFiling

  8. 8 Form 4 sale ALEXION PHARMACEUTICALS INCPlan not stated
    Mar 1, 2017 +20 days

    Sold 1,855 shares at $131.63 ($244k)

    Mackay Martin, EVP & Global Head of R&D

    Sold 3.5% of holdings ($6.9M position)50,688 shares left0.6x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (13)

Form 144 notices and Form 4 sales by Mackay Martin
Source
Mar 1, 2017Mar 1, 2017ALEXION PHARMACEUTICALS INCEVP & Global Head of R&DForm 4 sale1,855$244k3.5%Plan not statedSEC
Feb 9, 2017Feb 10, 2017ALEXION PHARMACEUTICALS INCEVP & Global Head of R&DForm 4 sale217$28k0.5%Plan not statedSEC
Feb 6, 2017Feb 8, 2017ALEXION PHARMACEUTICALS INCEVP & Global Head of R&DForm 4 sale2,728$343k6.4%Plan not statedSEC
May 16, 2016May 18, 2016ALEXION PHARMACEUTICALS INCEVP & Global Head of R&DForm 4 sale4,097$570k8.8%Plan not statedSEC
Feb 29, 2016Mar 1, 2016ALEXION PHARMACEUTICALS INCEVP & Global Head of R&DForm 4 sale1,000$139k2.1%Plan not statedSEC
Feb 8, 2016Feb 8, 2016ALEXION PHARMACEUTICALS INCEVP & Global Head of R&DForm 4 sale3,971$555k8.9%Plan not statedSEC
Aug 3, 2015Aug 5, 2015ALEXION PHARMACEUTICALS INCEVP & Global Head of R&DForm 4 sale43,500$8.5M56.9%UnusualSEC
May 14, 2015May 22, 2015ALEXION PHARMACEUTICALS INCEVP & Global Head of R&DForm 4 sale4,056$650k11.0%Plan not statedSEC
Mar 2, 2015Mar 3, 2015ALEXION PHARMACEUTICALS INCEVP & Global Head of R&DForm 4 sale370$67k1.0%Plan not statedSEC
Feb 10, 2015Feb 12, 2015ALEXION PHARMACEUTICALS INCEVP & Global Head of R&DForm 4 sale3,897$678k10.8%Plan not statedSEC
Nov 3, 2014Nov 4, 2014ALEXION PHARMACEUTICALS INCEVP & Global Head of R&DForm 4 sale9,375$1.8M27.7%UnusualSEC
Jun 12, 2014Jun 13, 2014ALEXION PHARMACEUTICALS INCEVP & Global Head of R&DForm 4 sale25,000$4.2M50.6%UnusualSEC
May 14, 2014May 15, 2014ALEXION PHARMACEUTICALS INCEVP & Global Head of R&DForm 4 sale3,574$575k12.8%Plan not statedSEC